Lorbrena

Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters
Fri, 05/31/24 - 10:44 am
Pfizer
Lorbrena
lung cancer
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda
Fierce Pharma
Thu, 03/4/21 - 11:21 pm
Pfizer
Lorbrena
non-small cell lung cancer
Novartis
Roche
Takeda
Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Fierce Pharma
Wed, 08/5/20 - 11:22 pm
Pfizer
Lorbrena
lung cancer
Xalkori
clinical trials
FDA approves Pfizer's treatment for certain lung cancer patients
Yahoo/Reuters
Sat, 11/3/18 - 12:33 pm
Pfizer
FDA
Lorbrena
ALK-positive non-small cell lung cancer